市場調查報告書
商品編碼
1028214

近紅外線光成像(NIR)市場:現狀分析與預測(2021年∼2027年)

Near Infrared Imaging (NIR) Market: Current Analysis and Forecast (2021-2027)

出版日期: | 出版商: UnivDatos Market Insights Pvt Ltd | 英文 178 Pages | 商品交期: 最快1-2個工作天內

價格
  • 全貌
  • 簡介
  • 目錄
簡介

近紅外線光成像(NIR),是一種新興技術,使用600至900nm範圍內的光來監測生物組織狀態的變化。由於世界範圍內外科手術數量增加、NIR成像技術的進步、NIR成像相對於傳統光譜方法的優勢,以及癌症、心血管疾病和胃腸道疾病事件增加,人口老齡化加劇也推動了市場成長。

本報告提供全球近紅外線光成像(NIR)市場調查,市場概要,各產品、用途、適應症、終端用戶、地區的詳細趨勢,收益趨勢,市場成長要素及課題,市場機會,價值鏈分析,競爭情形,主要企業簡介等彙整資訊。

目錄

第1章 簡介

  • 市場定義
  • 調查的目的
  • 限制
  • 相關利益者
  • 使用貨幣
  • 調查範圍

第2章 調查手法、前提條件

第3章 市場概要

第4章 摘要整理

第5章 近紅外線光成像(NIR)市場收益額(2019年∼2027年)

第6章 近紅外線光成像(NIR)市場洞察:各產品

  • 螢光成像
  • 試劑

第7章 近紅外線光成像(NIR)市場洞察:各用途

  • 前臨床
  • 臨床
  • 醫學

第8章 近紅外線光成像(NIR)市場洞察:各適應症

  • 癌症手術
  • 心臟血管手術
  • 腸胃手術
  • 整形外科、重組外科
  • 其他

第9章 近紅外線光成像(NIR)市場洞察:各終端用戶

  • 醫院、診療所
  • 研究所
  • 製藥、生物科技企業

第10章 近紅外線光成像(NIR)市場洞察:各地區

  • 北美
    • 美國
    • 加拿大
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 其他
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 其他
  • 其他地區

第11章 需求與供給側分析

  • 需求面分析
  • 供給側分析
    • 主要產品的銷售
    • 商務夥伴關係
    • 事業擴大、投資、出售
    • 合併、收購

第12章 價值鏈分析

第13章 市場趨勢、洞察

第14章 市場動態

  • 市場成長要素
  • 市場課題
  • 影響分析

第15章 市場機會

第16章 競爭模式

  • 波特的五力分析
    • 賣主談判力
    • 買方議價能力
    • 競爭企業間的敵對關係
    • 替代品的威脅
    • 新加入業者的威脅
  • 競爭情形

第17章 企業概要

  • Stryker
  • KARL STORZ SE & Co. KG
  • Carl Zeiss Meditec AG
  • Leica Microsystems
  • Olympus Corporation
  • PerkinElmer, Inc.
  • LI-COR, Inc.
  • Medtronic
  • Hamamatsu Photonics K.K.
  • Shimadzu Corporation

第18章 免責聲明

目錄
Product Code: UMHE21341

Near-infrared imaging (NIR) is an emerging technology that monitors the changes in the state of biological tissues using light in the range of 600 to 900 nm. The demand for NIR imaging is increasing on account of the growing number of surgical procedures all over the world, technological advancements in NIR imaging, advantages of NIR imaging over conventional methods of spectroscopy, Furthermore, the rising incidents of Cancer, Cardiovascular diseases, and Gastrointestinal diseases coupled with rising aging population also propels the market growth. As per the International Agency for Research on Cancer (IARC), 1 in 5 people will develop cancer during their lifetime and 1 in 11 women will die from cancer, globally.

However, some of the restraints in the market include the lengthy approval process that further limits the targeted fluorophore's availability.

Based on Product, the market is fragmented into Fluorescence Imaging and Reagents. The Fluorescence Imaging segment holds the largest share in 2020 and is expected to register the highest CAGR in the upcoming period owing to the rise in research activities, high advantages of near-infrared fluorescence imaging systems such as high image resolution, high sensitivity, and real-time image guidance during surgeries. Furthermore, the rising prevalence of cancer, gastrointestinal diseases, and cardiovascular diseases also intensifies the segment growth. As per the Centers for Disease Control and Prevention, there were 14.8 million adults were diagnosed with ulcers in 2018.

Based on Application, the market is fragmented into Preclinical, Clinical, and Medical. The Preclinical segment holds the largest share in 2020 and is expected to register the highest CAGR in the upcoming period owing to the increasing government support in the form of funding for biotech and pharma research. As per IBISWorld, it's evident that biotech is a multi-billion-dollar industry. Even before 2020 came to a close, the industry market size was over $100 billion. Moreover, the increasing focus on the development of new treatments for certain diseases such as cancer, angiogenesis, vascular diseases, and inflammation also drives the segment growth.

Based on Indication, the market is fragmented into Cancer Surgeries, Cardiovascular Surgeries, Gastrointestinal Surgeries, and Plastic/Reconstructive Surgeries. The Cancer Surgeries segment holds the largest share in 2020 and is expected to register the highest CAGR in the upcoming period owing to the rising prevalence of cancer cases all over the world. Cancer cases are continuously increasing on account of the lifestyle changes, rise in the geriatric population, and socioeconomic risk factors. Breast cancer accounts for the highest prevalence in the case of women owing to the genetic mutations in the BRCA1 and BRCA2 gene, radiation exposure, obesity, and postmenopausal hormonal therapy. As per the Centers for Disease Control and Prevention, Breast Cancer is the second most occurring cancer among women in the United States.

Based on End-user, the market is fragmented into Hospital & Clinics, Researchers Laboratories, and Biotechnology and Pharmaceutical Companies. The Hospital & Clinics segment holds the largest share in 2020 and is expected to register the highest CAGR in the upcoming period owing to rising clinical applications of NIR imaging in various therapeutic areas, the increase in demand for NIR imaging among clinicians across the world, and high advantages of NIR imaging systems in comparison to conventional imaging systems CT and MRI, such as high resolution and low cost.

For a better understanding of the market adoption of Near Infrared Imaging, the market is analyzed based on its worldwide presence in the countries such as North America (United States, Canada, and the Rest of North America), Europe (Germany, France, Italy, Spain, United Kingdom and Rest of Europe), Asia-Pacific (China, Japan, India, Australia, and Rest of APAC), and Rest of World. North America will dominate the Near Infrared Imaging market on account of the increasing geriatric population coupled with the rising prevalence of target diseases, high healthcare spending, a growing number of cosmetic surgeries, and high adoption of technologically advanced imaging systems. Some of the major players operating in the market include Stryker, KARL STORZ SE & Co. KG, Carl Zeiss Meditec AG, Leica Microsystems, Olympus Corporation, PerkinElmer, Inc., LI-COR, Inc., Medtronic, Hamamatsu Photonics K.K., and Shimadzu Corporation. Several M&As along with partnerships have been undertaken by these players to boost their presence in different regions

TABLE OF CONTENTS

1 MARKET INTRODUCTION

  • 1.1. Market Definitions
  • 1.2. Objective of the Study
  • 1.3. Limitation
  • 1.4. Stake Holders
  • 1.5. Currency Used in Report
  • 1.6. Scope of the Global Near Infrared Imaging Market Study

2 RESEARCH METHODOLOGY OR ASSUMPTION

  • 2.1. Research Methodology for the Global Near Infrared Imaging Market
    • 2.1.1. Main Objective of the Global Near Infrared Imaging Market

3 MARKET SYNOPSIS

4 EXECUTIVE SUMMARY

5 GLOBAL NEAR INFRARED IMAGING MARKET REVENUE (USD BN), 2019-2027F

6 MARKET INSIGHTS BY PRODUCT

  • 6.1. Fluorescence Imaging
  • 6.2. Reagents

7 MARKET INSIGHTS BY APPLICATION

  • 7.1. Preclinical
  • 7.2. Clinical
  • 7.3. Medical

8 MARKET INSIGHTS BY INDICATION

  • 8.1. Cancer Surgeries
  • 8.2. Cardiovascular Surgeries
  • 8.3. Gastrointestinal Surgeries
  • 8.4. Plastic/Reconstructive Surgeries
  • 8.5. Others

9 MARKET INSIGHTS BY END-USER

  • 9.1. Hospital & Clinics
  • 9.2. Researchers Laboratories
  • 9.3. Biotechnology and Pharmaceutical Companies

10 MARKET INSIGHTS BY REGION

  • 10.1. North America Near Infrared Imaging Market
    • 10.1.1. United States
    • 10.1.2. Canada
    • 10.1.3. Rest of North America
  • 10.2. Europe Near Infrared Imaging Market
    • 10.2.1. Germany
    • 10.2.2. France
    • 10.2.3. United Kingdom
    • 10.2.4. Italy
    • 10.2.5. Spain
    • 10.2.6. Rest of Europe
  • 10.3. Asia Pacific Near Infrared Imaging Market
    • 10.3.1. China
    • 10.3.2. Japan
    • 10.3.3. India
    • 10.3.4. Australia
    • 10.3.5. Rest of Asia Pacific
  • 10.4. Rest of the World Near Infrared Imaging Market

11 DEMAND AND SUPPLY SIDE ANALYSIS

  • 11.1. Demand Side Analysis
  • 11.2. Supply Side Analysis
    • 11.2.1. Top Product Launches
    • 11.2.2. Top Business Partnerships
    • 11.2.3. Top Business Expansions, Investments and Divestitures
    • 11.2.4. Top Merger and Acquisitions

12 VALUE CHAIN ANALYSIS

13 GLOBAL NEAR INFRARED IMAGING MARKET TRENDS & INSIGHTS

14 GLOBAL NEAR INFRARED IMAGING MARKET DYNAMICS

  • 14.1. Market Drivers
  • 14.2. Market Challenges
  • 14.3. Impact Analysis

15 GLOBAL NEAR INFRARED IMAGING MARKET OPPORTUNITIES

16 COMPETITIVE SCENARIO

  • 16.1. Porter's Five Forces Analysis
    • 16.1.1. Bargaining power of Supplier
    • 16.1.2. Bargaining power of Buyer
    • 16.1.3. Industry Rivalry
    • 16.1.4. Availability of Substitute
    • 16.1.5. Threat of new Entrants
  • 16.2 Competitive Landscape
    • 16.2.1 Company Shares, By Revenue

17 COMPANY PROFILED

  • 17.1. Stryker
  • 17.2. KARL STORZ SE & Co. KG
  • 17.3. Carl Zeiss Meditec AG
  • 17.4. Leica Microsystems
  • 17.5. Olympus Corporation
  • 17.6. PerkinElmer, Inc.
  • 17.7. LI-COR, Inc.
  • 17.8. Medtronic
  • 17.9. Hamamatsu Photonics K.K.
  • 17.10. Shimadzu Corporation

18 DISCLAIMER